Targeting Antifungal Resistance
Dec 21, 2017 | Schrödinger and MaRS Innovation Announce the Launch of Bright Angel Therapeutics
In the News
April 30, 2019 | Interview with Bright Angel Therapeutics Co-founder, Leah Cowen | Canadian Institute for the Advancement of Research (CIFAR)
April 12, 2019 | BIOCENTURY | Emerging Company Profile | Bright Angel: New hope against fungal resistance
March 18, 2018 | In Vivo Pharma Intelligence | vol. 36 no. 03 | Pages 12 – 17 | Will Advanced Technology Simulations Lead to More and Better Drugs? Start-up Schrödinger Says it Can.